Standard BioTools Statistics
Total Valuation
LAB has a market cap or net worth of $783.14 million. The enterprise value is $502.57 million.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LAB has 371.15 million shares outstanding. The number of shares has increased by 253.42% in one year.
| Current Share Class | 371.15M |
| Shares Outstanding | 371.15M |
| Shares Change (YoY) | +253.42% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 47.24% |
| Float | 236.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.76 |
| Forward PS | 3.46 |
| PB Ratio | 1.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.76 |
| Quick Ratio | 3.33 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.26 |
Financial Efficiency
Return on equity (ROE) is -37.25% and return on invested capital (ROIC) is -17.47%.
| Return on Equity (ROE) | -37.25% |
| Return on Assets (ROA) | -14.69% |
| Return on Capital (ROIC) | -17.47% |
| Revenue Per Employee | $289,243 |
| Profits Per Employee | -$231,148 |
| Employee Count | 539 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, LAB has paid $139,000 in taxes.
| Income Tax | 139,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.44% in the last 52 weeks. The beta is 1.57, so LAB's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +1.44% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 2.22 |
| Relative Strength Index (RSI) | 66.00 |
| Average Volume (20 Days) | 1,962,713 |
Short Selling Information
The latest short interest is 21.33 million, so 5.75% of the outstanding shares have been sold short.
| Short Interest | 21.33M |
| Short Previous Month | 21.29M |
| Short % of Shares Out | 5.75% |
| Short % of Float | 9.03% |
| Short Ratio (days to cover) | 16.02 |
Income Statement
In the last 12 months, LAB had revenue of $155.90 million and -$124.59 million in losses. Loss per share was -$0.45.
| Revenue | 155.90M |
| Gross Profit | 75.71M |
| Operating Income | -119.93M |
| Pretax Income | -118.58M |
| Net Income | -124.59M |
| EBITDA | -114.31M |
| EBIT | -119.93M |
| Loss Per Share | -$0.45 |
Full Income StatementBalance Sheet
The company has $366.33 million in cash and $89.47 million in debt, giving a net cash position of $276.86 million or $0.75 per share.
| Cash & Cash Equivalents | 366.33M |
| Total Debt | 89.47M |
| Net Cash | 276.86M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 489.33M |
| Book Value Per Share | 1.32 |
| Working Capital | 332.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$143.46 million and capital expenditures -$5.05 million, giving a free cash flow of -$148.51 million.
| Operating Cash Flow | -143.46M |
| Capital Expenditures | -5.05M |
| Free Cash Flow | -148.51M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 48.57%, with operating and profit margins of -76.92% and -79.91%.
| Gross Margin | 48.57% |
| Operating Margin | -76.92% |
| Pretax Margin | -79.83% |
| Profit Margin | -79.91% |
| EBITDA Margin | -73.32% |
| EBIT Margin | -76.92% |
| FCF Margin | -95.89% |